Shan L, Nakamura M, Nakamura Y, Inoue D, Morimoto S, Yokoi T, Kakudo K
Second Department of Pathology, Wakayama Medical College, Wakayama City, Japan.
Virchows Arch. 1997 Mar;430(3):247-51. doi: 10.1007/BF01324809.
Parathyroid adenoma and hyperplasia are the most common causes for hyperparathyroidism, and distinction between them is controversial based on the current criteria for pathological diagnosis. We studied the clonality of hyperparathyroidism and its correlation with the pathological features, analysing 39 female patients with hyperparathyroidism. Clonality was successfully detected in 12 heterozygous cases by PCR amplification of PGK-1 gene. The 12 cases yielded 14 hypercellular glands, 8 affected by primary and 6 by secondary hyperparathyroidism. The results revealed that 7 of the 8 glands with primary hyperparathyroidism showed monoclonal proliferation. Only 1 gland pathologically diagnosed as adenoma showed a polyclonal pattern. In the 4 cases with secondary hyperparathyroidism, at least one monoclonal tumour was detected in each case. Our data indicate that monoclonal tumours are more common than expected in both primary and secondary hyperparathyroidism. Monoclonal tumours and polyclonal hyperplasia can co-exist in the same patient. Comparative study of the clonality and the pathological features showed that the clonality was consistent with the diagnosis of parathyroid adenoma, whereas it was in conflict with the diagnosis of hyperplasia with multigland involvement. One of the reasons for this is that we are ignorant of the true natures of hyperparathyroidism with multigland involvement.
甲状旁腺腺瘤和增生是甲状旁腺功能亢进最常见的病因,根据目前的病理诊断标准,区分它们存在争议。我们研究了甲状旁腺功能亢进的克隆性及其与病理特征的相关性,分析了39例甲状旁腺功能亢进的女性患者。通过PGK-1基因的PCR扩增,在12例杂合子病例中成功检测到克隆性。这12例病例中有14个细胞增多的腺体,8个受原发性甲状旁腺功能亢进影响,6个受继发性甲状旁腺功能亢进影响。结果显示,8个原发性甲状旁腺功能亢进的腺体中有7个显示单克隆增殖。只有1个病理诊断为腺瘤的腺体显示多克隆模式。在4例继发性甲状旁腺功能亢进病例中,每例至少检测到1个单克隆肿瘤。我们的数据表明,单克隆肿瘤在原发性和继发性甲状旁腺功能亢进中比预期更常见。单克隆肿瘤和多克隆增生可在同一患者中共存。对克隆性和病理特征的比较研究表明,克隆性与甲状旁腺腺瘤的诊断一致,而与多腺体受累的增生诊断相矛盾。原因之一是我们对多腺体受累的甲状旁腺功能亢进的真正性质并不了解。